Who owns CULLINAN ONCOLOGY INC?
- Ticker: CGEM
- CUSIP Number: 230031106
Tip: Access positions for across all investors
Analyze quarterly positions in Cullinan Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cullinan Oncology stock
Who bought or sold CULLINAN ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MPM Oncology Impact Management | 7.6M | $130M | 0% | Mar 2024 |
|
| BVF | 3.2M | $55M | 0% | Mar 2024 |
|
| Blue Owl Capital Holdings | 2.9M | $50M | -14% | Mar 2024 |
|
| Franklin Resources | 2.7M | $46M | -18% | Mar 2024 |
|
| BlackRock | 2.4M | $41M | 9% | Mar 2024 |
|
| Vanguard Group | 1.8M | $30M | 0% | Mar 2024 |
|
| Paradigm Biocapital Advisors | 1.3M | $23M | 100% | Mar 2024 |
|
| Braidwell | 1.2M | $21M | 0% | Mar 2024 |
|
| American International | 1.2M | $13M | 0% | Dec 2023 |
|
| Nextech Invest | 1.2M | $21M | 0% | Mar 2024 |
|
| Morgan Stanley | 1.2M | $20M | 307% | Mar 2024 |
|
| Deerfield Management Company | 1.1M | $19M | 100% | Mar 2024 |
|
| Citadel Advisors | 1.1M | $19M | -2% | Mar 2024 |
|
| Dimensional Fund Advisors | 993k | $17M | 8% | Mar 2024 |
|
| Adage Capital Partners GP | 950k | $16M | -17% | Mar 2024 |
|
| Logos Global Management | 700k | $12M | 100% | Mar 2024 |
|
| Geode Capital Management | 677k | $12M | 15% | Mar 2024 |
|
| Rubric Capital Management | 627k | $11M | 0% | Mar 2024 |
|
| Tang Capital Management | 571k | $9.7M | -26% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 549k | $9.4M | 1% | Mar 2024 |
|
| OrbiMed Advisors | 518k | $8.8M | -5% | Mar 2024 |
|
| Ameriprise Financial | 420k | $7.2M | 571% | Mar 2024 |
|
| Northern Trust | 264k | $4.5M | 4% | Mar 2024 |
|
| Charles Schwab Investment Management | 258k | $4.4M | 5% | Mar 2024 |
|
| Parkman Healthcare Partners | 178k | $3.0M | -59% | Mar 2024 |
|
| Goldman Sachs Group | 169k | $2.9M | 32% | Mar 2024 |
|
| UBS Group | 167k | $2.8M | 18% | Mar 2024 |
|
| Bank of America Corporation | 131k | $2.2M | -3% | Mar 2024 |
|
| Qube Research & Technologies | 115k | $2.0M | 100% | Mar 2024 |
|
| Rafferty Asset Management | 97k | $1.7M | 100% | Mar 2024 |
|
| First Trust Advisors | 96k | $1.6M | 6% | Mar 2024 |
|
| Bank of New York Mellon | 94k | $1.6M | -5% | Mar 2024 |
|
| Nuveen Asset Management | 93k | $1.6M | 19% | Mar 2024 |
|
| Citigroup | 86k | $1.5M | 710% | Mar 2024 |
|
| Kennedy Capital Management | 84k | $1.4M | -47% | Mar 2024 |
|
| D. E. Shaw & Co | 62k | $1.1M | 26% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 60k | $1.0M | -57% | Mar 2024 |
|
| UBS O'Connor | 59k | $1.0M | 100% | Mar 2024 |
|
| American Century Companies | 57k | $974k | -80% | Mar 2024 |
|
| Cubist Systematic Strategies | 56k | $952k | -2% | Mar 2024 |
|
| Marshall Wace | 47k | $802k | 41% | Mar 2024 |
|
| Rhumbline Advisers | 47k | $796k | 2% | Mar 2024 |
|
| Swiss National Bank | 46k | $789k | 0% | Mar 2024 |
|
| Credit Suisse | 46k | $780k | 7% | Mar 2024 |
|
| Alliancebernstein | 43k | $442k | -1% | Dec 2023 |
|
| Martingale Asset Management | 43k | $433k | 0% | Dec 2023 |
|
| Algert Coldiron Investors | 41k | $418k | 148% | Dec 2023 |
|
| Barclays | 40k | $685k | -53% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 36k | $620k | 100% | Mar 2024 |
|
| Trexquant Investment | 35k | $356k | 100% | Dec 2023 |
|
| Susquehanna International | 35k | $590k | 50% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 32k | $543k | 100% | Mar 2024 |
|
| Nebula Research & Development | 25k | $420k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 24k | $405k | 14% | Mar 2024 |
|
| T. Rowe Price Associates | 23k | $390k | 4% | Mar 2024 |
|
| Hsbc Holdings | 22k | $221k | 0% | Dec 2023 |
|
| New York Life Investment Management | 21k | $362k | -37% | Mar 2024 |
|
| Jane Street | 21k | $358k | 52% | Mar 2024 |
|
| State of Wisconsin Investment Board | 20k | $342k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 20k | $334k | -49% | Mar 2024 |
|
| Legal & General Group | 20k | $333k | 40% | Mar 2024 |
|
| Jpmorgan Chase & Co | 20k | $332k | -23% | Mar 2024 |
|
| CornerCap Investment Counsel | 19k | $317k | -1% | Mar 2024 |
|
| Mirae Asset Global Investments | 17k | $181k | 22% | Mar 2024 |
|
| Exchange Traded Concepts | 17k | $287k | 20% | Mar 2024 |
|
| NEOS Investment Management | 16k | $279k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 16k | $279k | -54% | Mar 2024 |
|
| ProFund Advisors | 15k | $260k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 15k | $251k | -30% | Mar 2024 |
|
| MetLife Investment Advisors | 13k | $136k | 0% | Dec 2023 |
|
| Harbor Capital Advisors | 13k | $214k | -13% | Mar 2024 |
|
| Annandale Capital | 12k | $122k | 0% | Dec 2023 |
|
| Virtus ETF Advisers | 10k | $174k | -6% | Mar 2024 |
|
| SG Americas Securities | 9.9k | $169k | -31% | Mar 2024 |
|
| New York State Common Retirement Fund | 9.5k | $162k | 42% | Mar 2024 |
|
| Wells Fargo & Company | 9.2k | $157k | 15% | Mar 2024 |
|
| China Universal Asset Management | 9.0k | $153k | 82% | Mar 2024 |
|
| Quest Partners | 8.7k | $148k | -51% | Mar 2024 |
|
| Zurcher Kantonalbank | 5.1k | $87k | -22% | Mar 2024 |
|
| Summit Investment Advisors | 2.6k | $44k | 31% | Mar 2024 |
|
| Parallel Advisors | 1.3k | $22k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.3k | $13k | 0% | Dec 2023 |
|
| Point72 | 1.3k | $22k | 100% | Mar 2024 |
|
| Amalgamated Bank | 896.00 | $15k | -59% | Mar 2024 |
|
| Goss Wealth Management | 723.00 | $12k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 580.00 | $10k | -94% | Mar 2024 |
|
| FMR | 526.00 | $9.0k | -67% | Mar 2024 |
|
| GAMMA Investing | 496.00 | $8.5k | 20% | Mar 2024 |
|
| Signature | 451.00 | $7.7k | -47% | Mar 2024 |
|
| Pacer Advisors | 450.00 | $7.7k | 100% | Mar 2024 |
|
| Us Bancorp | 428.00 | $7.3k | -15% | Mar 2024 |
|
| Tower Research Capital | 325.00 | $5.5k | -98% | Mar 2024 |
|
| Quadrant Capital | 306.00 | $5.2k | 27% | Mar 2024 |
|
| Lindbrook Capital | 291.00 | $5.0k | 0% | Mar 2024 |
|
| NISA Investment Advisors | 138.00 | $2.4k | 18% | Mar 2024 |
|
| Daiwa Securities Group | 127.00 | $2.0k | 0% | Mar 2024 |
|
| Washington Trust Advisors | 127.00 | $2.2k | 0% | Mar 2024 |
|
| Brian McDonald | 122.00 | $2.1k | 0% | Mar 2024 |
|
| Simplex Trading | 119.00 | $2.0k | -77% | Mar 2024 |
|
| ClariVest Asset Management | 86.00 | $1.5k | 59% | Mar 2024 |
|
| Massmutual Trust | 36.00 | $613.000800 | 0% | Mar 2024 |
|
| CWM | 33.00 | $999.999000 | 14% | Mar 2024 |
|
| Group One Trading | 14.00 | $238.999600 | -100% | Mar 2024 |
|
| Pnc Financial Services | 13.00 | $221.999700 | -24% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $85.000000 | 100% | Mar 2024 |
|
Who sold out of Cullinan Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2023 | 233k | $2.4M |
| Hudson Bay Capital Management | Dec 2023 | 225k | $2.3M |
| Verition Fund Management | Sep 2023 | 210k | $1.9M |
| DAFNA Capital Management | Dec 2023 | 127k | $1.3M |
| Velan Capital Investment Management | Sep 2023 | 75k | $679k |
| Two Sigma Investments | Dec 2023 | 50k | $513k |
| Squarepoint Ops | Dec 2023 | 20k | $205k |
| Federated Investors | Sep 2023 | 20k | $181k |
| Svb Financial Group | Sep 2023 | 14k | $122k |
| Springbok Capital Management | Sep 2023 | 13k | $114k |
| Bailard | Dec 2023 | 11k | $110k |
| Ing Investment Management | Sep 2023 | 11k | $97k |
| Principal Financial Group | Dec 2023 | 11k | $109k |
| GSA Capital Partners | Dec 2023 | 10k | $104k |
| Vontobel Holding | Dec 2023 | 10k | $102k |
| Point72 Asia | Dec 2023 | 2.9k | $29k |
| Russell Investments | Dec 2023 | 2.3k | $23k |
| Point72 Middle East FZE | Dec 2023 | 1.2k | $12k |